APO RESEARCH · REPORT
Gene Synthesis Service
Gene synthesis refers to chemically synthesizing a strand of DNA base-by-base. Unlike DNA replication that occurs in cells or by Polymerase Chain Reaction (PCR), gene synthesis does not require a template strand. Rather, gene synthesis involves the step-wise addition of nucleotides to a single-stranded molecule, which then serves as a template for creation of a complementary strand. Gene synthesis is the fundamental technology upon which the field of synthetic biology has been built.
Product & engineering
Understand the product.
Gene synthesis refers to chemically synthesizing a strand of DNA base-by-base. Unlike DNA replication that occurs in cells or by Polymerase Chain Reaction (PCR), gene synthesis does not require a template strand. Rather, gene synthesis involves the step-wise addition of nucleotides to a single-stranded molecule, which then serves as a template for creation of a complementary strand. Gene synthesis is the fundamental technology upon which the field of synthetic biology has been built.
Selected research
Market Analysis & Forecast
Global Gene Synthesis Service Market Analysis and Forecast 2026-2032
Market perspective
Gene synthesis refers to chemically synthesizing a strand of DNA base-by-base. Unlike DNA replication that occurs in cells or by Polymerase Chain Reaction (PCR), gene synthesis does not require a template strand. Rather, gene synthesis involves the step-wise addition of nucleotides to a single-stranded molecule, which then serves as a template for creation of a complementary strand. Gene synthesis is the fundamental technology upon which the field of synthetic biology has been built.
North America is the largest consumption market, with a consumption market share nearly 36% . Followed by Asia Pacific is the second largest consumption place with the consumption market share of 33%. The key manufacturers are Genescript, GeneArt (Thermofischer), IDT, Eurofins Genomics, DNA 2.0 (ATUM), BBI, Genewiz, Gene Oracle, SBS Genetech, Bio Basic etc. Top 5 companies occupied about 72% market share.In terms of product, 1001 to 3000 bp is the largest segment, with a share over 35%. And in terms of application, the largest application is commercial, followed by academic research.
Report Includes
Read the full market overview
This report presents an overview of global market for Gene Synthesis Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Gene Synthesis Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Gene Synthesis Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Gene Synthesis Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Gene Synthesis Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Gene Synthesis Service revenue, projected growth trends, production technology, application and end-user industry.
Gene Synthesis Service Segment by Company
Genescript
GeneArt (Thermofischer)
IDT
Eurofins Genomics
DNA 2.0 (ATUM)
BBI
Genewiz
Gene Oracle
SBS Genetech
Bio Basic
Twist Bioscience
Gene Synthesis Service Segment by Type
Below 1000 bp
1001 to 3000 bp
3001 to 5000 bp
Above 5000 bp
Gene Synthesis Service Segment by Application
Commercial
Academic Research
Gene Synthesis Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Synthesis Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gene Synthesis Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Synthesis Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Gene Synthesis Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Gene Synthesis Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gene Synthesis Service revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Below 1000 bp
- 1001 to 3000 bp
- 3001 to 5000 bp
- Above 5000 bp
Applications
- Commercial
- Academic Research
Companies covered
- Genescript
- GeneArt (Thermofischer)
- IDT
- Eurofins Genomics
- DNA 2.0 (ATUM)
- BBI
- Genewiz
- Gene Oracle
- SBS Genetech
- Bio Basic
- Twist Bioscience
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Gene Synthesis Service Market by Type
- 1.2.1 Global Gene Synthesis Service Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Below 1000 bp
- 1.2.3 1001 to 3000 bp
- 1.2.4 3001 to 5000 bp
- 1.2.5 Above 5000 bp
- 1.3 Gene Synthesis Service Market by Application
- 1.3.1 Global Gene Synthesis Service Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Commercial
- 1.3.3 Academic Research
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Gene Synthesis Service Market Dynamics
- 2.1 Gene Synthesis Service Industry Trends
- 2.2 Gene Synthesis Service Industry Drivers
- 2.3 Gene Synthesis Service Industry Opportunities and Challenges
- 2.4 Gene Synthesis Service Industry Restraints
3 Global Growth Perspective
- 3.1 Global Gene Synthesis Service Market Perspective (2021-2032)
- 3.2 Global Gene Synthesis Service Growth Trends by Region
- 3.2.1 Global Gene Synthesis Service Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Gene Synthesis Service Market Size by Region (2021-2026)
- 3.2.3 Global Gene Synthesis Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Gene Synthesis Service Revenue by Players
- 4.1.1 Global Gene Synthesis Service Revenue by Players (2021-2026)
- 4.1.2 Global Gene Synthesis Service Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Gene Synthesis Service Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Gene Synthesis Service Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Gene Synthesis Service Key Players Headquarters & Area Served
- 4.4 Global Gene Synthesis Service Players, Product Type & Application
- 4.5 Global Gene Synthesis Service Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Gene Synthesis Service Market CR5 and HHI
- 4.6.3 2025 Gene Synthesis Service Tier 1, Tier 2, and Tier 3
5 Gene Synthesis Service Market Size by Type
- 5.1 Global Gene Synthesis Service Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Gene Synthesis Service Revenue by Type (2021-2032)
- 5.3 Global Gene Synthesis Service Revenue Market Share by Type (2021-2032)
6 Gene Synthesis Service Market Size by Application
- 6.1 Global Gene Synthesis Service Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Gene Synthesis Service Revenue by Application (2021-2032)
- 6.3 Global Gene Synthesis Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Genescript
- 7.1.1 Genescript Company Information
- 7.1.2 Genescript Business Overview
- 7.1.3 Genescript Gene Synthesis Service Revenue and Gross Margin (2021-2026)
- 7.1.4 Genescript Gene Synthesis Service Product Portfolio
- 7.1.5 Genescript Recent Developments
- 7.2 GeneArt (Thermofischer)
- 7.2.1 GeneArt (Thermofischer) Company Information
- 7.2.2 GeneArt (Thermofischer) Business Overview
- 7.2.3 GeneArt (Thermofischer) Gene Synthesis Service Revenue and Gross Margin (2021-2026)
- 7.2.4 GeneArt (Thermofischer) Gene Synthesis Service Product Portfolio
- 7.2.5 GeneArt (Thermofischer) Recent Developments
- 7.3 IDT
- 7.3.1 IDT Company Information
- 7.3.2 IDT Business Overview
- 7.3.3 IDT Gene Synthesis Service Revenue and Gross Margin (2021-2026)
- 7.3.4 IDT Gene Synthesis Service Product Portfolio
- 7.3.5 IDT Recent Developments
- 7.4 Eurofins Genomics
- 7.4.1 Eurofins Genomics Company Information
- 7.4.2 Eurofins Genomics Business Overview
- 7.4.3 Eurofins Genomics Gene Synthesis Service Revenue and Gross Margin (2021-2026)
- 7.4.4 Eurofins Genomics Gene Synthesis Service Product Portfolio
- 7.4.5 Eurofins Genomics Recent Developments
- 7.5 DNA 2.0 (ATUM)
- 7.5.1 DNA 2.0 (ATUM) Company Information
- 7.5.2 DNA 2.0 (ATUM) Business Overview
- 7.5.3 DNA 2.0 (ATUM) Gene Synthesis Service Revenue and Gross Margin (2021-2026)
- 7.5.4 DNA 2.0 (ATUM) Gene Synthesis Service Product Portfolio
- 7.5.5 DNA 2.0 (ATUM) Recent Developments
- 7.6 BBI
- 7.6.1 BBI Company Information
- 7.6.2 BBI Business Overview
- 7.6.3 BBI Gene Synthesis Service Revenue and Gross Margin (2021-2026)
- 7.6.4 BBI Gene Synthesis Service Product Portfolio
- 7.6.5 BBI Recent Developments
- 7.7 Genewiz
- 7.7.1 Genewiz Company Information
- 7.7.2 Genewiz Business Overview
- 7.7.3 Genewiz Gene Synthesis Service Revenue and Gross Margin (2021-2026)
- 7.7.4 Genewiz Gene Synthesis Service Product Portfolio
- 7.7.5 Genewiz Recent Developments
- 7.8 Gene Oracle
- 7.8.1 Gene Oracle Company Information
- 7.8.2 Gene Oracle Business Overview
- 7.8.3 Gene Oracle Gene Synthesis Service Revenue and Gross Margin (2021-2026)
- 7.8.4 Gene Oracle Gene Synthesis Service Product Portfolio
- 7.8.5 Gene Oracle Recent Developments
- 7.9 SBS Genetech
- 7.9.1 SBS Genetech Company Information
- 7.9.2 SBS Genetech Business Overview
- 7.9.3 SBS Genetech Gene Synthesis Service Revenue and Gross Margin (2021-2026)
- 7.9.4 SBS Genetech Gene Synthesis Service Product Portfolio
- 7.9.5 SBS Genetech Recent Developments
- 7.10 Bio Basic
- 7.10.1 Bio Basic Company Information
- 7.10.2 Bio Basic Business Overview
- 7.10.3 Bio Basic Gene Synthesis Service Revenue and Gross Margin (2021-2026)
- 7.10.4 Bio Basic Gene Synthesis Service Product Portfolio
- 7.10.5 Bio Basic Recent Developments
- 7.11 Twist Bioscience
- 7.11.1 Twist Bioscience Company Information
- 7.11.2 Twist Bioscience Business Overview
- 7.11.3 Twist Bioscience Gene Synthesis Service Revenue and Gross Margin (2021-2026)
- 7.11.4 Twist Bioscience Gene Synthesis Service Product Portfolio
- 7.11.5 Twist Bioscience Recent Developments
8 North America
- 8.1 North America Gene Synthesis Service Revenue (2021-2032)
- 8.2 North America Gene Synthesis Service Revenue by Type (2021-2032)
- 8.2.1 North America Gene Synthesis Service Revenue by Type (2021-2026)
- 8.2.2 North America Gene Synthesis Service Revenue by Type (2027-2032)
- 8.3 North America Gene Synthesis Service Revenue Share by Type (2021-2032)
- 8.4 North America Gene Synthesis Service Revenue by Application (2021-2032)
- 8.4.1 North America Gene Synthesis Service Revenue by Application (2021-2026)
- 8.4.2 North America Gene Synthesis Service Revenue by Application (2027-2032)
- 8.5 North America Gene Synthesis Service Revenue Share by Application (2021-2032)
- 8.6 North America Gene Synthesis Service Revenue by Country
- 8.6.1 North America Gene Synthesis Service Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Gene Synthesis Service Revenue by Country (2021-2026)
- 8.6.3 North America Gene Synthesis Service Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Gene Synthesis Service Revenue (2021-2032)
- 9.2 Europe Gene Synthesis Service Revenue by Type (2021-2032)
- 9.2.1 Europe Gene Synthesis Service Revenue by Type (2021-2026)
- 9.2.2 Europe Gene Synthesis Service Revenue by Type (2027-2032)
- 9.3 Europe Gene Synthesis Service Revenue Share by Type (2021-2032)
- 9.4 Europe Gene Synthesis Service Revenue by Application (2021-2032)
- 9.4.1 Europe Gene Synthesis Service Revenue by Application (2021-2026)
- 9.4.2 Europe Gene Synthesis Service Revenue by Application (2027-2032)
- 9.5 Europe Gene Synthesis Service Revenue Share by Application (2021-2032)
- 9.6 Europe Gene Synthesis Service Revenue by Country
- 9.6.1 Europe Gene Synthesis Service Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Gene Synthesis Service Revenue by Country (2021-2026)
- 9.6.3 Europe Gene Synthesis Service Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Gene Synthesis Service Revenue (2021-2032)
- 10.2 China Gene Synthesis Service Revenue by Type (2021-2032)
- 10.2.1 China Gene Synthesis Service Revenue by Type (2021-2026)
- 10.2.2 China Gene Synthesis Service Revenue by Type (2027-2032)
- 10.3 China Gene Synthesis Service Revenue Share by Type (2021-2032)
- 10.4 China Gene Synthesis Service Revenue by Application (2021-2032)
- 10.4.1 China Gene Synthesis Service Revenue by Application (2021-2026)
- 10.4.2 China Gene Synthesis Service Revenue by Application (2027-2032)
- 10.5 China Gene Synthesis Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Gene Synthesis Service Revenue (2021-2032)
- 11.2 Asia Gene Synthesis Service Revenue by Type (2021-2032)
- 11.2.1 Asia Gene Synthesis Service Revenue by Type (2021-2026)
- 11.2.2 Asia Gene Synthesis Service Revenue by Type (2027-2032)
- 11.3 Asia Gene Synthesis Service Revenue Share by Type (2021-2032)
- 11.4 Asia Gene Synthesis Service Revenue by Application (2021-2032)
- 11.4.1 Asia Gene Synthesis Service Revenue by Application (2021-2026)
- 11.4.2 Asia Gene Synthesis Service Revenue by Application (2027-2032)
- 11.5 Asia Gene Synthesis Service Revenue Share by Application (2021-2032)
- 11.6 Asia Gene Synthesis Service Revenue by Country
- 11.6.1 Asia Gene Synthesis Service Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Gene Synthesis Service Revenue by Country (2021-2026)
- 11.6.3 Asia Gene Synthesis Service Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Gene Synthesis Service Revenue (2021-2032)
- 12.2 SAMEA Gene Synthesis Service Revenue by Type (2021-2032)
- 12.2.1 SAMEA Gene Synthesis Service Revenue by Type (2021-2026)
- 12.2.2 SAMEA Gene Synthesis Service Revenue by Type (2027-2032)
- 12.3 SAMEA Gene Synthesis Service Revenue Share by Type (2021-2032)
- 12.4 SAMEA Gene Synthesis Service Revenue by Application (2021-2032)
- 12.4.1 SAMEA Gene Synthesis Service Revenue by Application (2021-2026)
- 12.4.2 SAMEA Gene Synthesis Service Revenue by Application (2027-2032)
- 12.5 SAMEA Gene Synthesis Service Revenue Share by Application (2021-2032)
- 12.6 SAMEA Gene Synthesis Service Revenue by Country
- 12.6.1 SAMEA Gene Synthesis Service Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Gene Synthesis Service Revenue by Country (2021-2026)
- 12.6.3 SAMEA Gene Synthesis Service Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst